BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12094555)

  • 1. Topoisomerase II inhibitors--teaching old dogs new tricks.
    Sharma S
    Cancer Invest; 2002; 20(4):596-7. PubMed ID: 12094555
    [No Abstract]   [Full Text] [Related]  

  • 2. Topoisomerase II inhibitors.
    Clapp JM; Hande KR
    Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
    [No Abstract]   [Full Text] [Related]  

  • 3. Topoisomerase II inhibitors.
    Toonen TR; Hande KR
    Cancer Chemother Biol Response Modif; 2001; 19():129-47. PubMed ID: 11686011
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
    Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
    Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase expression in tumors--a novel target for chemotherapy.
    Rubin EH
    Hum Pathol; 2000 Jun; 31(6):631-2. PubMed ID: 10872653
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA topoisomerase II as a target for cancer chemotherapy.
    Walker JV; Nitiss JL
    Cancer Invest; 2002; 20(4):570-89. PubMed ID: 12094551
    [No Abstract]   [Full Text] [Related]  

  • 7. From DNA damage to G2 arrest: the many roles of topoisomerase II.
    Larsen AK; Escargueil AE; Skladanowski A
    Prog Cell Cycle Res; 2003; 5():295-300. PubMed ID: 14593724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN-10755. Menarini.
    Jones K
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topoisomerase II as a cellular receptor of various antineoplastic drugs].
    Szmigiero L
    Postepy Biochem; 1988; 34(3):147-52. PubMed ID: 2855749
    [No Abstract]   [Full Text] [Related]  

  • 11. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
    Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
    Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical structural motif for the catalytic inhibition of human topoisomerase II by UK-1 and analogs.
    Wang BB; Maghami N; Goodlin VL; Smith PJ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3221-6. PubMed ID: 15149679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
    Furet P; Schoepfer J; Radimerski T; Chène P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging DNA topisomerase inhibitors as anticancer drugs.
    Denny WA
    Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
    Han S; Xiao Z; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel homogenous assay for topoisomerase II action and inhibition.
    Jahnz M; Medina MA; Schwille P
    Chembiochem; 2005 May; 6(5):920-6. PubMed ID: 15812853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.